Patel, H.; Mishra, R.; Yacoub, N.; Alanazi, S.; Kilroy, M.K.; Garrett, J.T.
IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in BRAF-Mutant Melanoma. Cancers 2021, 13, 5863.
https://doi.org/10.3390/cancers13225863
AMA Style
Patel H, Mishra R, Yacoub N, Alanazi S, Kilroy MK, Garrett JT.
IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in BRAF-Mutant Melanoma. Cancers. 2021; 13(22):5863.
https://doi.org/10.3390/cancers13225863
Chicago/Turabian Style
Patel, Hima, Rosalin Mishra, Nour Yacoub, Samar Alanazi, Mary Kate Kilroy, and Joan T. Garrett.
2021. "IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in BRAF-Mutant Melanoma" Cancers 13, no. 22: 5863.
https://doi.org/10.3390/cancers13225863
APA Style
Patel, H., Mishra, R., Yacoub, N., Alanazi, S., Kilroy, M. K., & Garrett, J. T.
(2021). IGF1R/IR Mediates Resistance to BRAF and MEK Inhibitors in BRAF-Mutant Melanoma. Cancers, 13(22), 5863.
https://doi.org/10.3390/cancers13225863